Perspective Therapeutics, Inc. · AMEX:CATX
Lantheus Alpha Therapy, LLC sold 113,914 Perspective Therapeutics, Inc. shares (Form 4)
Traded Aug 31 to Sep 1, 2026 · Filed Sep 4, 2026
From Aug 31 to Sep 1, 2026, Lantheus Alpha Therapy, LLC (10% owner) sold 113,914 Perspective Therapeutics, Inc. shares at an average US$3.13 for US$357K, leaving 11,563,425 shares. Filed Sep 4, 2026 (Form 4).
- Sold
- 113,914 shares
- Price
- US$3.13 average (US$3.12 to US$3.14)
- Value
- US$357K
- Holding after
- 11,563,425 shares
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 31, 2026 | Common Stock | Sale | 78,145 | US$3.14 | 11,599,194 | Direct |
| Sep 1, 2026 | Common Stock | Sale | 35,769 | US$3.12 | 11,563,425 | Direct |
Source
Related
- Perspective Therapeutics, Inc.
- Lantheus Alpha Therapy, LLC
- Perspective Therapeutics, Inc. shareholders
- Form 4 · Lantheus Alpha Therapy, LLC · Sep 8, 2026
- Schedule 13D/A · Lantheus Holdings, Inc. · Sep 23, 2026
- Form 4 · Lantheus Holdings, Inc. · Sep 4, 2026
- Schedule 13D/A · Lantheus Holdings, Inc. · Sep 4, 2026
- Form 4 · Lantheus Holdings, Inc. · Sep 3, 2026
- Form 4 · Lantheus Holdings, Inc. · Sep 2, 2026